CytoMed Therapeutics LtdGDTCEarnings & Financial Report
Nasdaq
NextMar 13, 2026
GDTC Q2 2025 Key Financial Metrics
Revenue
$155.9K
Gross Profit
N/A
Operating Profit
N/A
Net Profit
N/A
Gross Margin
N/A
Operating Margin
N/A
Net Margin
N/A
YoY Growth
N/A
Financial Flow
CytoMed Therapeutics Ltd Q2 2025 Financial Summary
CytoMed Therapeutics Ltd reported revenue of $155.9K for Q2 2025, with a net profit of N/A (N/A margin). Cost of goods sold was N/A, operating expenses totaled N/A.
Key Financial Metrics
| Total Revenue | $155.9K |
|---|---|
| Net Profit | N/A |
| Gross Margin | N/A |
| Operating Margin | N/A |
| Report Period | Q2 2025 |
Income Statement
| Q2 2025 | |
|---|---|
| Revenue | $155887 |
| YoY Growth | N/A |
Balance Sheet
| Q2 2025 | |
|---|---|
| Assets | N/A |
| Liabilities | N/A |
| Equity | N/A |
Cash Flow
| Q2 2025 | |
|---|---|
| Operating CF | $-1.2M |